Sunday - December 22, 2024

Methods for Aiding in the Diagnosis and Determination of the Extent of Traumatic Brain Injury in a Human Subject Using the Early Biomarker Ubiquitin Carboxy-Terminal Hydrolase L1

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- ABBOTT LABORATORIES, Abbott Park, Illinois has been assigned a patent (No. US 12163958 B2, initially filed May 10, 2021) developed by four inventors Beth McQuiston, Abbott Park, Illinois; Justin Rogers, Abbott Park, Illinois; Saul Datwyler, Abbott Park, Illinois; and Jaime Marino, Abbott Park, Illinois, for "Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Methods for Aiding in the Diagnosis and Determination of the Extent of Traumatic Brain Injury in a Human Subject Using the Early Biomarker Ubiquitin Carboxy-Terminal Hydrolase L1

Information Request Form

Copyright Targeted News Service 2024